Increased diabetes risk and prevalence form the cornerstone of metabolic ab
normalities in women with polycystic ovary syndrome (PCOS). Women with PCOS
have multiple risk factors for diabetes including obesity, a family histor
y of type 2 diabetes, and abnormalities in insulin action. Studies of gluco
se tolerance in urban and rural populations have shown rates of glucose int
olerance approaching 40% in reproductive-aged women with PCOS who have poor
correlation with fasting glucose levels. Impaired glucose tolerance may id
entify a group of women at increased risk for cardiovascular disease. These
findings justify vigilant screening for these abnormalities and appropriat
e interventions in a PCOS population.